These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1961870)

  • 41. Chronic fatigue syndrome: prevalence and outcome.
    Lawrie SM; Pelosi AJ
    BMJ; 1994 Mar; 308(6931):732-3. PubMed ID: 8142823
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic fatigue syndrome: the fundamentals still apply.
    Manu P
    Am J Med; 2000 Feb; 108(2):172-3. PubMed ID: 11126312
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chronic fatigue syndrome].
    Kitani T
    Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1571-6. PubMed ID: 8245661
    [No Abstract]   [Full Text] [Related]  

  • 44. Postviral fatigue syndrome and the VP-1 antigen.
    Lynch S; Seth R
    Lancet; 1989 Nov; 2(8672):1160-1. PubMed ID: 2572886
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of arousal in predictive coding.
    Ferreira-Santos F
    Behav Brain Sci; 2016 Jan; 39():e207. PubMed ID: 28347383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can we really know if a stressor increases or decreases natural killer cell activity?
    Ben-Eliyahu S
    Brain Behav Immun; 2012 Nov; 26(8):1224-5. PubMed ID: 22890132
    [No Abstract]   [Full Text] [Related]  

  • 47. Letter to the editor.
    Van Houdenhove B
    Semin Arthritis Rheum; 2003 Oct; 33(2):134-5. PubMed ID: 14625821
    [No Abstract]   [Full Text] [Related]  

  • 48. Chronic fatigue study shows syndrome's complexity.
    Couzin-Frankel J
    Science; 2024 Feb; 383(6685):804-805. PubMed ID: 38386732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of laboratory findings for patients with chronic fatigue syndrome.
    Buchwald D; Komaroff AL
    Rev Infect Dis; 1991; 13 Suppl 1():S12-8. PubMed ID: 1902321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chronic fatigue immune dysfunction syndrome].
    Uchida A
    Nihon Rinsho; 1992 Nov; 50(11):2625-9. PubMed ID: 1287238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of a laboratory stressor on natural killer cell function in chronic fatigue syndrome patients.
    Wemm KM; Trestman RL
    Psychosomatics; 1991; 32(4):470-1. PubMed ID: 1961870
    [No Abstract]   [Full Text] [Related]  

  • 52. Premorbid "overactive" lifestyle and stress-related pain/fatigue syndromes.
    Van Houdenhove B
    J Psychosom Res; 2005 Apr; 58(4):389-90. PubMed ID: 15992575
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunodysregulation and chronic fatigue syndrome.
    Kundu SK; Ahronheim GA; Menezes J
    Can Dis Wkly Rep; 1991 Jan; 17 Suppl 1E():49-50. PubMed ID: 1669353
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunity and depression: insomnia, retardation, and reduction of natural killer cell activity.
    Cover H; Irwin M
    J Behav Med; 1994 Apr; 17(2):217-23. PubMed ID: 8035453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome.
    Ojo-Amaize EA; Conley EJ; Peter JB
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S157-9. PubMed ID: 8148445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal.
    Morriss RK; Robson MJ; Deakin JF
    Psychopharmacology (Berl); 2002 Sep; 163(2):166-73. PubMed ID: 12202963
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.